CEO & FounderFounder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Eli Lilly and Company (NYSE:LLY) on Monday announced positive topline results from the Phase 3 ADorable-1 trial evaluating EBGLYSS (lebrikizumab-lbkz) in patients aged six months to 18 years with moderate-to-severe atopic dermatitis.
WaterBridge Infrastructure (NYSE:WBI) reported its full-year 2025 financial results on Monday, highlighting a transformative year defined by its September initial public offering and the strategic combination of its legacy operating entities.
A potential US ban on stablecoin yield products could prompt other jurisdictions to introduce the feature instead, according to Takatoshi Shibayama of crypto hardware wallet firm Ledger.
Former UK Prime Minister Boris Johnson has called Bitcoin a Ponzi scheme, prompting widespread backlash from cryptocurrency industry leaders and commentators.
Researchers are warning of a sharp rise in address poisoning scams across Ethereum following the network’s Fusaka upgrade.
The proposed CLARITY Act may face slim chances of passing this year if it fails to advance within the next several weeks, according to industry analysts.
Global mining giant South32 (ASX:S32) placed its Mozal Aluminium smelter on "care and maintenance" as of March 15.
Enterprise Metals has announced high-grade assay results from its maiden reverse circulation (RC) drilling program at the Cuddingwarra North rare earth element (REE) project in Western Australia.
The 14-hole program targeting the Emily Well prospect saw 13 holes intersect total rare earth oxides (TREO) above 300ppm, with 10 holes exceeding 400ppm.
Recon Technology (NASDAQ:RCON) reported a significant improvement in its financial performance for the first six months of fiscal year 2026, ending December 31, 2025.
bioAffinity Technologies (NASDAQ:BIAF) reported fiscal year 2025 results that underscore an aggressive transition from a broad laboratory service model to a specialized, high-growth diagnostic powerhouse focused on early-stage lung cancer detection.
